MBX Biosciences, Inc. MBX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from MBX Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s cash ratio?
- MBX Biosciences, Inc. (MBX) reported cash ratio of 3.1× in Q1 2026.
- How has MBX Biosciences, Inc.'s cash ratio changed year-over-year?
- MBX Biosciences, Inc.'s cash ratio increased by 8.8% year-over-year, from 2.9× to 3.1×.
- What is the long-term trend for MBX Biosciences, Inc.'s cash ratio?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s cash ratio has grown at a -20.9% compound annual growth rate (CAGR), from 7.8× to 4.9×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.